Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MJ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-19772US
JN.1.39.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.58.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.18.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LF.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.441NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.509NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.293NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.225NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.637NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.39 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.26 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.103 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.3 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.18.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LE.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDQNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.502NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.285NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.582NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.580NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.306NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.280NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.329NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
ME.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LE.1.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDR.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.49.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HV.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.15.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JD.1.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.25NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.2.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GJ.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DY.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.14.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.3.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DY.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used